Seaweed Extract Supplementation and Metabolic Biomarkers

Launched by BIOATLANTIS LTD. · Feb 22, 2019

Keywords

ClinConnect Summary

Diabetes melitus is a group of metabolic disorders resulting from a defect in insulin production and/or insulin action. The World Health Organisation (WHO) has estimated that the total number of people with diabetes mellitus worldwide will increase from 171 million in 2000 to nearly 370 million in 2030 with the prevalence of the disease for all age groups to be 4.4%. 90% of diabetes cases worldwide are of Type II diabetes mellitus (T2DM) as a result of greater prevalence of sedentary lifestyle, unhealthy diet and rise of obesity, as well as an increasing number of elderly population. T2DM c...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Body Mass Index (BMI) 25-35 kg/m2
• • Not dieting within the last month and not having lost \>5% body weight in the previous year
• • Not increased physical activity levels in the past 2-4 weeks or intending to modify them during the study
• • Understands and is willing, able and likely to comply with all study procedures and restriction including being willing to follow the nutritional advice
• • Able to eat most everyday foods
• • Habitually consumes three standard meals a day
• Exclusion Criteria:
• • Significant health problems (e.g. hypercholesterolaemia, diabetes, GI disorders)
• • Taking any medication or supplements known to affect mineral or glucose metabolism within the past month and/or during the study
• • Pregnant, planning to become pregnant or breastfeeding
• • History of anaphylaxis to food
• • Known allergies or intolerance to foods and/or to the study materials (or closely related compounds) or any of their stated ingredients
• • BMI \<25 kg/m2 or \>35 kg/m2
• • Volunteers self-reporting currently dieting or having lost \>5% body weight in the previous year
• • Participants with abnormal eating behaviour
• • Participation in another experimental study or receipt of an investigational drug/product within 30 days of the screening visit
• • Volunteers who have significantly changed their physical activity in the past 2-4 weeks or who intend to change them during the study
• • Participants receiving systemic or local treatment likely to interfere with the evaluation of the study parameters
• • Participants on specific food avoidance diets
• • Participants who work in appetite or feeding related areas